Monday, December 18, 2017

Real Time Search

Plant-Based Vaccine Company to Bring 85 Jobs to RTP

Carolina Headlines - Bioscience

DURHAM, NC – Gov. Bev Perdue on Aug. 10 announced that Medicago USA Inc. will locate a new vaccine production facility in Durham. The company is a wholly owned subsidiary of Medicago, Inc., a publicly traded company based in Quebec, Canada. The firm plans to create 85 jobs in Research Triangle Park. The project was made possible in part by a US$128,000 grant from the One North Carolina Fund. The N.C. Dept. of Commerce's Garrett Wyckoff was the developer on this project.

The Defense Advanced Research Projects Agency (DARPA) has awarded Medicago a $21 million research grant to improve the process of large-quantity H1N1 vaccine production using plant-based technology. The company is currently using tobacco leaves to produce pandemic and seasonal influenza vaccines. Medicago's project with DARPA will lead to a total investment of more than $32 million in Research Triangle Park.

Market Watch

Ads on: Special HTML

Login Form